title: What is the potential of syndecan-4-targeted novel delivery technologies?
authors.affiliation: Institute of Biology, University of West Hungary, Savaria University Centre, Szombathely, Hungary and CEO Szilak Laboratories Ltd, Szeged, Hungary. laszlo.szilak@gmail.com.
authors.forename: Laszlo
authors.initials: L
authors.lastname: Szilak
authors.forename: Tamas
authors.initials: T
authors.lastname: Letoha
authors.forename: Bettina
authors.initials: B
authors.lastname: Ughy
mesh_terms: D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004705:Endocytosis; D011992:Endosomes; D019812:Heparan Sulfate Proteoglycans / Q000502:physiology; D006801:Humans; D011956:Receptors, Cell Surface / Q000378:metabolism; D013347:Subcellular Fractions / Q000378:metabolism; D053671:Syndecan-4 / Q000737:chemistry*
chemical_list: D004337:Drug Carriers; D019812:Heparan Sulfate Proteoglycans; D011956:Receptors, Cell Surface; D053671:Syndecan-4